Back to search

Article

Therapeutic validation of MMR-associated genetic modifiers in a human <i>ex vivo</i> model of Huntington’s disease

2023-12-07

Abstract excerpt

<h4>ABSTRACT</h4> The pathological huntingtin ( HTT ) trinucleotide repeat underlying Huntington’s disease (HD) continues to expand throughout life. Repeat length correlates both with earlier age at onset (AaO) and faster progression, making slowing its expansion an attractive therapeutic approach. Genome-wide association studies have identified candidate variants associated with altered AaO and progression, wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80d8b54c-b9cd-5830-8ade-7f02bf68d9b1
DOI
10.1101/2023.12.05.570095
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutic validation of MMR-associated genetic modifiers in a human <i>ex vivo</i> model of Huntington’s diseaseDOI 10.1101/2023.12.05.570095
Select a neighboring publication to make it the new centre.